|
871 |
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
Enthalten in Nature medicine 17.10.2022: 1-2
|
|
|
|
872 |
A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge
Enthalten in Psychopharmacology 15.10.2022: 1-13
|
|
|
|
873 |
The Therapeutic Role of Rho Kinase Inhibitor, Fasudil, on Pulmonary Hypertension; a Systematic Review and Meta-Analysis
Enthalten in Drug research 10.10.2022
|
|
|
|
874 |
Lactobacillus-rhamnosus -Supplementation bei pädiatrischen Mukoviszidose-Patienten – nur das (Mikrobiom-) Ergebnis zählt?
Enthalten in Karger-Kompass Pneumologie Bd. 10, 2022, Nr. 6: 298-300. 3 S.
|
|
|
|
875 |
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
Enthalten in Cancer immunology immunotherapy 5.10.2022: 1-10
|
|
|
|
876 |
Bullöses Pemphigoid: Ein small molecule zeigt großes Potenzial
Enthalten in Karger-Kompass Dermatologie Bd. 10, 2022, Nr. 4: 181-183. 3 S.
|
|
|
|
877 |
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial
Enthalten in Nature medicine 4.10.2022: 1
|
|
|
|
878 |
Atopische Dermatitis: Endlich kein Off-Label Use mehr bei Therapie im Kindesalter!?
Enthalten in Karger-Kompass Dermatologie Bd. 10, 2022, Nr. 2: 70-72. 3 S.
|
|
|
|
879 |
PharmaNews
Enthalten in Karger-Kompass Dermatologie Bd. 10, 2022, Nr. 1: 41-44. 4 S.
|
|
|
|
880 |
Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
Enthalten in International urology and nephrology 1.10.2022: 1-8
|
|
Administration
